14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
IBHK vs IBHJ: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, iShares iBonds 2030 Term High Yield and Income ETF (IBHJ) is the stronger overall head-to-head candidate over iShares iBonds 2031 Term High Yield and Income ETF (IBHK) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). IBHK carries a Unified Composite Score of 45.6/100 (HOLD) at $24.33 (N/M Forward P/E, N/A operating margin), whereas IBHJ carries 44.6/100 (HOLD) at $25.48 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While IBHK currently prints a higher short-term Unified Composite Score (45.6/100 HOLD vs. IBHJ 44.6/100 HOLD), IBHJ captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Technical & Structure Timing Caution: IBHK is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.3); meanwhile IBHJ is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IBHK vs IBHJ. Trailing 12-month operating profitability (IBHK N/A vs IBHJ N/A) and valuation multiples (IBHK N/M vs IBHJ N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ IBHK vs IBHJ Key Questions & Quantitative Answers
As of Nov 16, 2026, iShares iBonds 2030 Term High Yield and Income ETF (IBHJ) is the stronger overall head-to-head candidate over iShares iBonds 2031 Term High Yield and Income ETF (IBHK) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). IBHK carries a Unified Composite Score of 45.6/100 (HOLD) at $24.33 (N/M Forward P/E, N/A operating margin), whereas IBHJ carries 44.6/100 (HOLD) at $25.48 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While IBHK currently prints a higher short-term Unified Composite Score (45.6/100 HOLD vs. IBHJ 44.6/100 HOLD), IBHJ captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: IBHK is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.3); meanwhile IBHJ is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
IBHK and IBHJ split Growth & Scale metrics: IBHK posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with IBHJ at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, IBHK generates N/A in USD-normalized revenue versus N/A for IBHJ. In operating R&D and SG&A reinvestment, IBHK deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for IBHJ.
IBHK and IBHJ trade at balanced relative valuation multiples. IBHK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas IBHJ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IBHK (N/A ROE) versus IBHJ (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, IBHK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.26β · 7% Vol realized risk). By comparison, IBHJ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.17β · 6% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.